GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 4,512 | 2,848 | 5,595 | 3,382 | 1,513 |
| Operating Income | -4,512 | -2,848 | -5,595 | -3,382 | -1,513 |
| Interest Expense | 64 | 63 | 0 | 0 | 0 |
| Other Income | 58 | 78 | -113 | 11,681 | -28,656 |
| Pre-tax Income | -4,518 | -2,833 | -5,708 | 8,299 | -30,169 |
| Net Income Continuous | -4,518 | -2,833 | -5,708 | 8,299 | -30,169 |
| Net Income | $-4,518 | $-2,833 | $-5,708 | $8,299 | $-30,169 |
| EPS Basic Total Ops | -0.12 | -0.11 | 3.53 | 1.04 | -10.92 |
| EPS Basic Continuous Ops | -0.12 | -0.09 | 3.97 | 2.11 | -10.88 |
| EPS Diluted Total Ops | -0.12 | -0.11 | 3.53 | 1.04 | -10.92 |
| EPS Diluted Continuous Ops | -0.12 | -0.09 | 3.97 | 2.11 | -10.88 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.11 | -0.02 | -0.83 | -0.55 |
| EBITDA(a) | $-4,512 | $-2,848 | $-5,595 | $-3,382 | $-1,513 |